Table 1 Demographic and clinical characteristics of MS patients on account of treatment
IFN B 1B group (n = 9) | NTZ group (n = 10) | p-value | |
|---|---|---|---|
Women/men | 3/6 | 6 /4 | 0.18 |
Mean age, (range) [years] | 39 (24–48) | 43 (20–60) | 0.46 |
Median disease duration, (range) [years] | 12 (2–23) | 10 (5–17) | 0.71 |
Median NTZ infusions (range) [years] | 21 (12–49) | 25.5 (13–45) | 0.66 |
Annualized relapse rate during NTZ treatment | 0 (0) | 0 (0–1.3) | 0.50 |
Median EDSS (range) [years] | 3.0 (1.5-3.5) | 3.0 (1.5-3.5) | 0.71 |